---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-048186"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2023-09-14T23:59:59+00:00"
generated_at: "2026-06-10T17:31:44.125697+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# HeartSciences Q1 FY2024: no revenue, $576K cash; MyoVista FDA submission targeted for late 2023

## Summary
- No revenue for Q1 FY2024; cash and equivalents of $576K as of July 31, 2023.
- Completed enrollment for MyoVista pivotal study; targeting FDA submission in late 2023.
- Expanded IP portfolio to 41 patents (9 US, 32 international); appointed new distributors in Nordic and India.
- Secured $15M equity line (March 2023) and $1M promissory note (Sept 2023) for funding.

## SEC filing metadata
- accession: 0000950170-23-048186
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2023-09-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017023048186/0000950170-23-048186-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017023048186/hscs-20230914.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-048186
- JSON: https://secwatch.observer/filing/0000950170-23-048186.json
- Plain text: https://secwatch.observer/filing/0000950170-23-048186.txt

## Key facts
- Earnings Releases
  HeartSciences Inc. reported the first quarter fiscal 2024 ended July 31, 2023 results: revenue There were no revenues.
  - Period: the first quarter fiscal 2024 ended July 31, 2023
  - Revenue: There were no revenues
  - Result: reported results
  source text: HeartSciences Reports First Quarter Fiscal 2024 Financial Results
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000095017023048186/0000950170-23-048186-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.